CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic

Background: Clopidogrel (Plavix) is an antiplatelet medication that is routinely used in patients with cardiovascular disease. Cytochrome P2C19 enzymes play a major role in its metabolism, which determines its varied therapeutic level and its effectiveness. Objectives: To customize clopidogrel thera...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Community Hosp Intern Med Perspect
Egile Nagusiak: Mirabbasi, Seyed abbas, Khalighi, Koroush, Wu, Yin, Walker, Stanley, Khalighi, Bahar, Fan, Wuqiang, Kodali, Archana, Cheng, Gang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2017
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538219/
https://ncbi.nlm.nih.gov/pubmed/28808507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2017.1347475
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak